Asked by: Navendu Mishra (Labour - Stockport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 April 2024 to Question 20454 on Mental Health Services: Stockport, what the average financial spend was per child and young person supported; and what the average number of contacts was per child and young person supported.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Data from 1 April 2022 to 31 March 2023 shows the average cost per contact is £333, and that then Pennine Care NHS Foundation Trust received over 8,000 referrals, with a 96% acceptance rate. This is only for the children and young people’s mental health service provided by Pennine Care in Stockport. There may be other services and support, but to collate this would exceed the appropriate limit.
Asked by: Navendu Mishra (Labour - Stockport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 April 2024 to Question 21865 on Bowel Cancer: Greater Manchester, what is the average waiting time to receive (a) an appointment for a coloscopy and (b) the results from a colonoscopy in (i) England, (ii) Greater Manchester and (iii) Stepping Hill Hospital.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Statistics on diagnostics waiting times via modality for England, and at commissioner and provider levels, is publicly available and can be accessed via the following link:
Asked by: Navendu Mishra (Labour - Stockport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help improve specialist services for patients diagnosed with myalgic encephalomyelitis.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Integrated care boards (ICBs) are responsible for commissioning specialist myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome (CFS), services that meet the needs of their population, subject to local prioritisation and funding. The process of commissioning services should take into account best practice guidance, such as the National Institute for Health and Care Excellence’s (NICE) guidance on ME and CFS diagnosis and management, published in October 2021.
In October 2023, the British Association of Clinicians in ME/CFS published the ME/CFS National Services Survey. This report provides insight into the services being delivered for adults, children, and young people with ME and CFS. The Department published My full reality: an interim delivery plan for ME/CFS in August 2023, which sets out a number of actions to improve the experiences and outcomes for people living with the condition, including better education of professionals and improvements to service provision.
Alongside the publication of the interim delivery plan, we ran a public consultation to build a picture of how well the interim plan meets the needs of the ME and CFS community, and to understand if there are any gaps where further action may be necessary. The Department is currently analysing over 3,000 responses to the consultation, and will publish a summary of the consultation responses in due course. Those consultation responses, along with continued close engagement with key stakeholders, will drive the development of the final cross-Government ME/CFS Delivery Plan, which will be published later this year.
Asked by: Navendu Mishra (Labour - Stockport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 April 2024 to Question 20454 on Mental Health Services: Stockport, how the £4.7 billion of increased funding for mental health has been spent; and how much and what proportion of that funding has been spent by (a) local authority and (b) constituency area.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Whilst a definitive answer is not possible, most of this additional funding was allocated to local health systems to be spent on expanding and transforming mental health services across the country. This is evidenced by:
- an increase in the number of adults accessing NHS Talking Therapies, with nearly 6 million people being supported over this five year period; an increase in the number of children and young people accessing mental health support, with over 750,000 children and young people under 18 years old supported through National Health Service funded mental health services, those with at least one contact, over the 12 months to January 2024;
- the roll out of approximately 400 mental health support teams in schools and colleges; the transformation of community mental health services for adults with approximately 288,000 adults and older adults with severe mental illness able to access improved physical health care, employment support, personalised and trauma informed care, medicines management and support for self-harm, and coexisting substance use over 2022/23, the latest full financial year for which figures are available;
- the establishment of around the clock and all-age urgent mental health helplines in every part of England;
- the investment of £30 million to meet the health needs of people sleeping rough, allowing for the establishment of 37 sites with new mental health provision for rough sleepers;
- the opening, or planned opening, of 15 specialist gambling treatment clinics, achieving representation across every region of England and including specialist provision for children and young people;
- the provision of £57 million of funding up to the end of March 2024, to embed local suicide and self-harm prevention activity, and to provide suicide bereavement support services in every local area.
Asked by: Navendu Mishra (Labour - Stockport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will provide a timescale of when she expects (a) NHS England to conclude its commercial negotiations with Vertex Pharmaceuticals and (b) NICE to issue final guidance on NHS availability of Kaftrio for new patients.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Commercial negotiations between NHS England and Vertex remain on track and are being undertaken constructively, and within a confidential environment, to best enable progress. NHS England remains committed to ensuring patients, and the wider community of family, carers, and friends, are provided with regular updates as negotiations continue.
Notwithstanding the ongoing commercial negotiations, the existing agreement contains a flexible commercial mechanism that will ensure continued access for patients already receiving any of the licensed treatments, whatever the outcome of the final National Institute for Health and Care Excellence (NICE) evaluation. Eligible children and adults with cystic fibrosis are continuing to receive ongoing treatment, and will be initiated onto treatment with these drugs as clinically appropriate. An update on the anticipated date of final guidance publication will be provided by the NICE once the commercial negotiations have concluded.
Asked by: Navendu Mishra (Labour - Stockport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 21 March 2024 to Question 17965 on Stepping Hill Hospital: Repairs and Maintenance, what assessment her Department has made of the potential impact of the state of repair of buildings at Stepping Hill hospital on capacity in (a) Stockport and (b) Greater Manchester.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department does not currently collect information on the impact of the condition of the National Health Service estate on capacity. However, we recognise the importance of modern healthcare estates in tackling hospital waiting lists. We are investing significant sums to upgrade and modernise NHS buildings, so staff have the facilities needed to provide world-class care for patients, including £4.2 billion this financial year for trusts to spend on necessary maintenance and repairs. This is on top of expected investment of over £20 billion in the New Hospital Programme, as well as £1.7 billion for over 70 hospital upgrades across England.
Asked by: Navendu Mishra (Labour - Stockport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 25 April 2024 to Question 23061 on Cancer: Health Services, what steps she is taking to ensure that NHS trusts have sufficient cancer treatment capacity to adequately support the number of people that are being diagnosed.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Government has allocated an additional £8 billion across this Spending Review period, to increase capacity and support elective recovery. Cancer treatment levels are at a record high, with approximately 345,000 people having received their first cancer treatment in the twelve months to February 2024.
As outlined in the 2024/25 NHS England Planning Guidance, NHS England is providing over £266 million in cancer service development funding to Cancer Alliances, to support the delivery of the operational priorities for cancer.
We are expanding capacity through our community diagnostic centres (CDCs), supported by £2.3 billion of capital funding, with 160 CDCs currently operational and having delivered almost 8 million additional tests, checks, and scans, including vital cancer checks.
Asked by: Navendu Mishra (Labour - Stockport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 29 April 2024 to Question 23065 on NHS: Databases, if he will hold discussions with the Federation of Clinical Registries on the (a) procurement and (b) centralising of clinical registries by the Medical Devices Outcome Registry programme.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
NHS England’s Patient Outcomes and Registries Programme is not centralising all clinical registries. The programme is: providing a new, improved national approach to NHS England funded clinical registries that optimises the security and use of patient data to improve patient safety vigilance and to improve patient outcomes, innovation, and value; and expanding the coverage of NHS England’s clinical registries and patient reported outcome measurement into new areas, to meet the independent Cumberlege and Paterson enquiry requirements to improve patient outcomes. The programme is undertaking extensive engagement, and we propose that any meetings with specific stakeholder groups about the programme are organised via the Medical Devices Outcome Registry Programme Director.
Asked by: Navendu Mishra (Labour - Stockport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to paragraph 3.64 of the NHS Long Term Plan, published in January 2019, what steps she is taking to ensure that every person diagnosed with cancer will have access to (a) personalised care, (b) a needs assessment, (c) a care plan and (d) health and wellbeing information and support.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Ensuring every person diagnosed with cancer has access to personalised care and support is a key priority for the Government. The NHS Long Term Plan for cancer states that where appropriate, every person diagnosed with cancer will have access to personalised care, including needs assessment, a care plan, and health and wellbeing information and support. NHS England is committed to ensuring that all cancer patients have access to a Holistic Needs Assessment and Personalised Care and Support Planning, ensuring care is focused on what matters most to each person. Additionally, End of Treatment Summaries are being introduced, which aims to empower people to manage the impact of their cancer after treatment. Health and wellbeing information and support is provided from diagnosis onwards, and includes access to NHS Talking Therapy services for anxiety and depression. This is alongside wider work to improve psychosocial support for people affected by cancer, such as through local partnerships with cancer support charities.
NHS England and the integrated care boards are responsible for commissioning and ensuring that the healthcare needs of local communities in England are met, including for cancer patients. NHS England provides access to a personal health budget, which is an amount of National Health Service money that is allocated to support the health and wellbeing needs of a patient, if eligible. Further information is available at the following link:
https://www.nhs.uk/nhs-services/help-with-health-costs/what-is-a-personal-health-budget/
Asked by: Navendu Mishra (Labour - Stockport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 April 2024 to Question 21490 on Prosthetics, if her Department will make an assessment of the potential merits of updating the stock of prosthetic limbs available.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The NHS Supply Chain framework for prosthetic componentry will be subject to its next routine procurement exercise in the autumn of 2024, with contracts awarded to commence on 1 April 2025. This does not preclude devices currently not on the framework from being prescribed by prosthetic centres as they are able to order directly from the manufacturer, and report via the exceptions log managed by NHS Supply Chain.